AstraZeneca United States
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for AstraZeneca United States based on listed parameters only.
The articles listed below published by authors from AstraZeneca United States, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
ACS Nano |
1 | 0.13 |
American Journal of Respiratory and Critical Care Medicine |
1 | 0.38 |
Annals of the Rheumatic Diseases |
1 | 0.20 |
Blood |
2 | 0.26 |
Chest |
2 | 0.36 |
Clinical Infectious Diseases |
1 | 0.08 |
Diabetes Care |
1 | 0.13 |
European Heart Journal |
2 | 0.23 |
JAMA: The Journal of the American Medical Association |
1 | 0.03 |
Journal of Biological Chemistry |
1 | 0.54 |
Journal of Clinical Investigation |
3 | 1.10 |
Journal of Clinical Oncology |
2 | 0.17 |
Journal of Infectious Diseases |
2 | 1.40 |
Journal of the American Chemical Society |
1 | 0.20 |
Journal of the American Society of Nephrology |
1 | 0.15 |
Nature |
3 | 0.15 |
Nature Communications |
11 | 1.76 |
Nature Genetics |
1 | 0.02 |
Nature Medicine |
1 | 0.82 |
Organic Letters |
1 | 1.00 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.27 |
Science |
1 | 0.01 |
Science Advances |
1 | 0.05 |
Science Translational Medicine |
2 | 0.62 |
The Lancet Oncology |
1 | 0.07 |
The New England Journal of Medicine |
1 | 0.04 |
Thorax |
1 | 0.13 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.